1. Home
  2. ARTL vs RPGL Comparison

ARTL vs RPGL Comparison

Compare ARTL & RPGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$0.73

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Logo Republic Power Group Limited Class A Ordinary Shares

RPGL

Republic Power Group Limited Class A Ordinary Shares

HOLD

Current Price

$2.19

Market Cap

2.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTL
RPGL
Founded
2011
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.3M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
ARTL
RPGL
Price
$0.73
$2.19
Analyst Decision
Hold
Analyst Count
2
0
Target Price
N/A
N/A
AVG Volume (30 Days)
173.0K
244.3K
Earning Date
05-13-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$21.40
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$0.21
52 Week High
$19.91
$13.06

Technical Indicators

Market Signals
Indicator
ARTL
RPGL
Relative Strength Index (RSI) 32.33 57.24
Support Level $0.71 $0.31
Resistance Level $1.87 $2.65
Average True Range (ATR) 0.06 0.20
MACD 0.02 0.05
Stochastic Oscillator 13.56 37.82

Price Performance

Historical Comparison
ARTL
RPGL

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About RPGL Republic Power Group Limited Class A Ordinary Shares

Republic Power Group Ltd is a provider of customized ERP software solutions, consulting and technical support services, and peripheral hardware to corporate clients and government agencies, including airports, cruise terminals, and technology, trading, and logistics companies. The Company operates from Singapore and has historically served clients in Singapore and Malaysia, offering ERP systems with functions such as accounting, procurement, workflow automation, real-time monitoring, and capabilities including planning, surveillance, and threat detection. The Company leverages artificial intelligence and modular algorithms to address complex operational requirements and integrates sensors, controls, and other hardware to enable IoT connectivity with autonomous or semiautonomous outcomes.

Share on Social Networks: